| pubmed-article:15288290 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C1261473 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C2699414 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C1516477 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C0220611 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
| pubmed-article:15288290 | lifeskim:mentions | umls-concept:C0205087 | lld:lifeskim |
| pubmed-article:15288290 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:15288290 | pubmed:dateCreated | 2004-8-3 | lld:pubmed |
| pubmed-article:15288290 | pubmed:abstractText | The aim of our study was to describe late failures in children who initially survived event-free five years from a diagnosis of rhabdomyosarcoma. Charts of children enrolled in the Intergroup Rhabdomyosarcoma Study Group (IRSG) trials III, IV pilot and IV (1984-1997) who survived five years event-free and subsequently experienced an adverse event (disease recurrence, second malignant neoplasm or death from other causes) were reviewed. Of the 2534 enrolled patients, 1160 were event-free at five years and 48 subsequently experienced a late event. The estimated 10-year event rate for the 1160 patients who were alive and event-free at five years was 9% (95% Confidence Interval (CI) 5%, 13%). Patients with both advanced disease (Group III/IV) and large primary tumours at diagnosis (> 5 cm) were at the highest risk for late events (19%; 95% CI 8%, 30%). Late events after successful treatment for rhabdomyosarcoma occur in 9%. Those with advanced disease and large primary tumours have the highest risk of late events. | lld:pubmed |
| pubmed-article:15288290 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15288290 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15288290 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15288290 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15288290 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15288290 | pubmed:issn | 0959-8049 | lld:pubmed |
| pubmed-article:15288290 | pubmed:author | pubmed-author:AndersonJames... | lld:pubmed |
| pubmed-article:15288290 | pubmed:author | pubmed-author:DonaldsonSara... | lld:pubmed |
| pubmed-article:15288290 | pubmed:author | pubmed-author:CristWilliam... | lld:pubmed |
| pubmed-article:15288290 | pubmed:author | pubmed-author:SpuntSheri... | lld:pubmed |
| pubmed-article:15288290 | pubmed:author | pubmed-author:SungLillianL | lld:pubmed |
| pubmed-article:15288290 | pubmed:author | pubmed-author:PappoAlberto... | lld:pubmed |
| pubmed-article:15288290 | pubmed:author | pubmed-author:Soft Tissue... | lld:pubmed |
| pubmed-article:15288290 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15288290 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:15288290 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15288290 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15288290 | pubmed:pagination | 1878-85 | lld:pubmed |
| pubmed-article:15288290 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:meshHeading | pubmed-meshheading:15288290... | lld:pubmed |
| pubmed-article:15288290 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15288290 | pubmed:articleTitle | Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. | lld:pubmed |
| pubmed-article:15288290 | pubmed:affiliation | The Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ont., M5G 1X8, Canada. | lld:pubmed |
| pubmed-article:15288290 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15288290 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15288290 | lld:pubmed |
